Increased alveolar soluble ANXA5 was observed in human bronchoalveolar lavage fluids (BALF) with interstitial lung disease, and its expression significantly increased in serum and lung tissues in silica‐exposed mice [35, 36]. Here, ANXA5 is linked to interstitial lung disease.